Articles
Page 14 of 34
-
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P149
-
Autoimmune sequelae in severe drug eruptions
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P147 -
Drug hypersensitivity in children in Brazil
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P145 -
Hypersensitivity to glucorticoids in children
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P143 -
Is an extensive allergy diagnosis workup needed in all cases of suspected hypersensitivity to beta-lactams in children?
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P141 -
Drug-induced skin reaction elicited by clindamycin and penicillin: one rash, but two culprits
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P139 -
Multiple drug hypersensitivity to beta lactam and non beta lactam antibiotics, inhibitors of conversion enzyme, thiopental and COX2 inhibitors on a hyperthyroid male patient - case report
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P137 -
Evaluation of a pharmacogenetic test in Thailand for abacavir hypersensitivity screening in human immunodeficiency virus infection
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P122 -
HLA-B*58:01 allele is strongly associated with allopurinol-induced severe cutaneous adverse reactions in a Thai population
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P120 -
Polymorfism Of CYP2C9 And 3A5 and carbamazepine hypersensitivity reactions in Brazilian subjects
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P118 -
Isoniazid-specific T-cell Responses in patients with anti-tuberculosis drug related liver injury
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P116 -
Skewing of the TCR V repertoire in SMX-NO specific T cell responses
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P114 -
Establishment of an HLA-typed cohort of 1000 healthy blood donors and use of a dendritic cell priming assay to prime naive T cells to structurally divergent drugs
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P112 -
HLA-DQ restricted activation of nitroso-sulfamethoxazole-specific CD4+ T-lymphocytes
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P110 -
Detection of interleukin-22 secreting T-cells in piperacillin hypersensitive patients with cystic fibrosis
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P108 -
Usefulness of patch tests in drug adverse reaction induced by tetrazepam and anti-inflammatory drugs
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P106 -
Hypersensitivity to antiretroviral drugs a case report
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P104 -
Attempts to standardize intradermal drug tests based on molecular mass and on clinical phenotypes. Some pitfalls or exceptions?
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P102 -
A mild form of a Stevens-Johnson syndrome to ciprofloxacin
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P93 -
Levofloxacin induced Stevens-Johnson syndrome/ toxic epidermal necrolysis overlap syndrome: case reports
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P91 -
Fluconazole-induced erythema fixum and edema of the upper lip
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P87 -
Allergy to ophthalmic solutions
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P85 -
Neutrophlic dermatosis (Sweet's syndrome-like) induced by paracetamol
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P83 -
Celecoxib induced bullous eruption confirmed by a patch test
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P81 -
Colloidal silica-induced hypersensitivity: myth or reality topics: clinical cases/case series: non-immediate elayed T cells IgG
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P79 -
A restrospective review of fixed drug eruptions presenting at a tertiary dermatology centre in Singapore between 2008 and 2012
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P77 -
Bromoderma caused by over-the-counter analgesic mimicking pyoderma gangrenosum
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P73 -
An 11-year-old boy with immediate allergic reaction to articaine but not to lidocaine
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P71 -
Chlorhexidine in cosmetic products a market survey
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P69 -
Hypersensitivity reactions to biologic disease modifying antirheumatic drugs: experience from the TTSH Singapore biologics registry
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P54 -
Galactose-ƒ¿-1,3-galactose (ƒ¿-gal)-specific IgE test is highly useful for predicting cetuximab-induced anaphylaxis
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P52 -
Drugs inducing T-cell mediated cutaneous adverse reactions and contact sensitizers evoke similar responses in THP-1 cells
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P50 -
Patrolling monocytes sensing herpes simplex virus in severe drug eruption
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P46 -
Analysis of B cell subsets in severe cutaneous adverse reaction
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P44 -
Characterization of amoxicillin and clavulanic-acid-responsive CD4+ And CD8+ T-cells in patients with co-amoxiclav-induced liver injury
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P42 -
Chemical modification of the 6'-amino cyclopropyl of abacavir eliminates HLA-B*57:01-restricted CD8+ T-cell activation without loss of antiviral activity
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P40 -
Abacavir forms novel cross-linking abacavir protein adducts in patients
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P38 -
Desensitization induces hyporesponsiveness and cell-surface phenotype changes on mouse mast cells
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P36 -
Basophil activation test in allergic patients to platins undergoing rapid desensitization
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P34 -
The role of malignancy in the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P21 -
Allopurinol is the most common cause of DRESS syndrome in Hungarian patients
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P17 -
Effects of immunomodulating therapies on mortality in patients with severe cutaneous adverse reactions in comparison with supportive care only: a systematic review
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P15 -
Association between HLA-B*13:01 and DIHS/DRESS due to dapson in a Japanese patients of pityriasis lichenoides et varioliformis acuta (PLEVA)
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P13 -
DNA copy number variations in drug reaction with eosinophilia and systemic symptoms (DRESS) identifying 2 new candidates genes
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):O11 -
Strong association between hla-a*02:06 and acetaminophen-related stevens-johnson syndrome with severe mucosal involvements in the Japanese
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P11 -
The "nocebo effect" in drug hypersensitivity diagnosis
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):O9 -
Diagnostic usefulness of histamine release test (HRT) and skin tests in IgE-mediated allergy to clavulanic acid
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):O7 -
Identification of susceptible HLA class II co-amoxiclav genotypes based on the analysis of drug-specific T-cells from patients with liver injury
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):O3 -
Nonirritant concentrations and amount of active ingredient in drug patch tests optimal concentrations for DPTs
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):P1 -
Mechanisms that limit proliferative potential of drug-specific LTT in drug-induced severe cutaneous adverse reaction patients
Citation: Clinical and Translational Allergy 2014 4(Suppl 3):O1